Big pharma argues poor nations can t be trusted to make vaccines Quartz 1 hr ago Annalisa Merelli © Provided by Quartz South African flag flies beside a flag bearing the logo of the vaccine manufacturing and storage company Biovac in Cape Town
When it comes to the suspension of patents for Covid-19 vaccines, it’s big pharma against the world or most of it, anyway.
Earlier this month, the US government expressed its support of a waiver to the international agreements governing intellectual property rights. The waiver, proposed in November 2020 by India and South Africa, would allow poor countries to produce Covid-19 vaccines without paying pharmaceutical companies for patent rights, at least until the pandemic is over. This would help increase the global supply of vaccines at a lower price, and make progress toward the goal of vaccinating the global population by the end of the year.
G20 takes lead on managing response to COVID-19
napaneeguide.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from napaneeguide.com Daily Mail and Mail on Sunday newspapers.
Jaishankar meets Defence Secy Austin, discusses India-US strategic and defence partnership
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.